UCSF Coronavirus Response: UCSF is partnering with public agencies to address the rapidly evolving outbreak and protect our communities. The UCSF COVID-19 Resources Website provides guidance and information for our patients, faculty, staff, trainees and learners.

Simon Paul

Title(s)Professor, Dean'S Office
SchoolSchool of Medicine
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Simon Paul, M.D.
    Associate Professor, UCSF
    Assistant Dean for Academic Affairs, UCSF Fresno
    HIV Director, UCSF Fresno
    Medical Director, Special Services, Community Regional Medical Center

    Simon Paul, M.D., specializes in Infectious Diseases and HIV. He is board certified in Internal Medicine. His fellowship training was with NIH Physicians Scientist Fellowship at the Rockefeller University. He attended medical school at Cornell University Medical College and completed his residency training at Parkland Memorial Hospital.

    Collapse Research 
    Collapse Research Activities and Funding
    Change in Lactate Metabolism on Antiretroviral Therapy
    NIH R21AI058770Jul 1, 2004 - Jun 30, 2007
    Role: Principal Investigator
    NIH K11AI001071Apr 1, 1992 - Mar 31, 1997
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Mu A, Shein TT, Jayachandran P, Paul S. Immune Reconstitution Inflammatory Syndrome in Patients with AIDS and Disseminated Coccidioidomycosis: A Case Series and Review of the Literature. J Int Assoc Provid AIDS Care. 2017 Nov/Dec; 16(6):540-545. PMID: 28911256.
      View in: PubMed
    2. Paul S, Mortimer RB, Mitchell M. Sertraline demonstrates fungicidal activity in vitro for Coccidioides immitis. Mycology. 2016; 7(3):99-101. PMID: 30123621.
      View in: PubMed
    3. Mu A, Rutledge J, Mills P, Paul S. Incidence of Kaposi's sarcoma and associated mortality in Fresno, California, 1998 to 2012. J Int Assoc Provid AIDS Care. 2014 Nov-Dec; 13(6):526-8. PMID: 24739208.
      View in: PubMed
    4. Paul S, Bogdanov MB, Matson WR, Metakis L, Jacobs J, Beal MF. Urinary 8-hydroxy-2'-deoxyguanosine, a metabolite of oxidized DNA, is not elevated in HIV patients on combination antiretroviral therapy. Free Radic Res. 2003 May; 37(5):499-502. PMID: 12797469.
      View in: PubMed
    5. Casau NC, Glesby MJ, Paul S, Gulick RM. Brief report: efficacy and treatment-limiting toxicity with the concurrent use of lopinavir/ritonavir and a third protease inhibitor in treatment-experienced HIV-infected patients. J Acquir Immune Defic Syndr. 2003 Apr 15; 32(5):494-8. PMID: 12679700.
      View in: PubMed
    6. Paul S, Gilbert HM, Lande L, Vaamonde CM, Jacobs J, Malak S, Sepkowitz KA. Impact of antiretroviral therapy on decreasing hospitalization rates of HIV-infected patients in 2001. AIDS Res Hum Retroviruses. 2002 May 01; 18(7):501-6. PMID: 12015903.
      View in: PubMed
    7. Paul S. Prioritization of medical problems to improve adherence. Clin Pharmacol Ther. 2002 Apr; 71(4):211-3. PMID: 11956502.
      View in: PubMed